Browse Studies — Arctuva

Phase 1

Novel Pilot Study to Treat Symptoms of IBS With Diarrhea Using Combination Therapy of a Low-FODMAP Diet and a Neuromodulator

The purpose of this research is to study the added benefit of treating IBS symptoms with a medication called mirtazapine in treating IBS symptoms when paired w…

IBS - Irritable Bowel SyndromeDiarrhea

Estimated

~$10 – $6,250

Mayo ClinicNCT06684470

Phase 1

Pilot Proof of Concept Study Evaluating the Potential Psilocybin Assisted Psychotherapy (PAP) as a Therapeutic Tool for Patients Suffering From Severe Irritable Bowel Syndrome.

This study will serve as a pilot randomized controlled trial to assess the feasibility of Psilocybin-Assisted Psychotherapy (PAP) in Treating Irritable Bowel S…

IBS - Irritable Bowel Syndrome

Estimated

~$10 – $7,500

NYU Langone HealthNCT06760533

Phase 2

The Use of Directed Probiotics in ME/CFS: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

This clinical study aims to evaluate the use of i3.1 probiotic in participants who meet the Institute of Medicine (Canadian Consensus Criteria) case definition…

ME/CFSIBS - Irritable Bowel Syndrome

Estimated

~$10 – $6,250

Nova Southeastern UniversityNCT06211062

Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease

We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.

IBS - Irritable Bowel SyndromeHealthyFunctional Bloating+1 more

Estimated

~$10 – $750

Stanford UniversityNCT06215222